$RGEN
REPLIGEN CORP Stock $rgen

$rgen Overview Financials Valuation SEC Filings Company Website

2015 Q2 Form 10-Q Financial Statement

#000119312515280610 Filed on August 06, 2015

Income Statement

Concept	2015 Q2	2014 Q2
Revenue	$21.46M	$15.55M
YoY Change	37.98%	-11.18%
Cost Of Revenue	$8.586M	$6.671M
YoY Change	28.71%	25.92%
Gross Profit	$12.87M	$8.880M
YoY Change	44.94%	-27.28%
Gross Profit Margin	59.99%	57.1%
Selling, General & Admin	$6.242M	$4.326M
YoY Change	44.29%	38.48%
% of Gross Profit	48.5%	48.72%
Research & Development	$1.252M	$1.430M
YoY Change	-12.45%	-37.99%
% of Gross Profit	9.73%	16.1%
Depreciation & Amortization	$1.150M	$970.0K
YoY Change	18.56%	40.58%
% of Gross Profit	8.93%	10.92%
Operating Expenses	$7.494M	$5.756M
YoY Change	30.19%	6.0%
Operating Profit	$4.609M	$3.106M
YoY Change	48.39%	-49.11%
Interest Expense	$8.000K	$13.00K
YoY Change	-38.46%	4.82%
% of Operating Profit	0.17%	0.42%
Other Income/Expense, Net	-$269.0K	$65.00K
YoY Change	-513.85%	-153.28%
Pretax Income	$4.351M	$3.243M
YoY Change	34.17%	-46.25%
Income Tax	$738.0K	$418.0K
% Of Pretax Income	16.96%	12.89%
Net Earnings	$3.613M	$2.825M
YoY Change	27.89%	-37.76%
Net Earnings / Revenue	16.84%	18.17%
Basic Earnings Per Share	$0.11	$0.09
Diluted Earnings Per Share	$0.11	$0.09
COMMON SHARES
Basic Shares Outstanding	32.87M shares	32.23M shares
Diluted Shares Outstanding	33.67M shares	33.08M shares

Balance Sheet

Concept	2015 Q2	2014 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$63.20M	$50.00M
YoY Change	26.4%	-13.94%
Cash & Equivalents	$40.01M	$33.76M
Short-Term Investments	$23.20M	$16.30M
Other Short-Term Assets	$800.0K	$1.600M
YoY Change	-50.0%	-20.0%
Inventory	$14.31M	$12.82M
Prepaid Expenses
Receivables	$14.42M	$9.004M
Other Receivables	$500.0K	$400.0K
Total Short-Term Assets	$93.27M	$73.86M
YoY Change	26.28%	-8.72%
LONG-TERM ASSETS
Property, Plant & Equipment	$14.46M	$12.55M
YoY Change	15.25%	27.57%
Goodwill	$14.35M	$13.35M
YoY Change	7.45%	1243.26%
Intangibles	$13.59M	$16.12M
YoY Change	-15.67%	148.03%
Long-Term Investments	$1.200M	$11.90M
YoY Change	-89.92%	158.7%
Other Assets	$500.0K	$500.0K
YoY Change	0.0%	-72.22%
Total Long-Term Assets	$44.08M	$55.19M
YoY Change	-20.14%	132.48%
TOTAL ASSETS
Total Short-Term Assets	$93.27M	$73.86M
Total Long-Term Assets	$44.08M	$55.19M
Total Assets	$137.3M	$129.0M
YoY Change	6.43%	23.31%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$4.303M	$3.896M
YoY Change	10.46%	163.02%
Accrued Expenses	$11.52M	$4.920M
YoY Change	134.21%	-43.7%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$15.83M	$8.815M
YoY Change	79.52%	-13.73%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$3.296M	$4.663M
YoY Change	-29.3%	135.07%
Total Long-Term Liabilities	$3.296M	$4.663M
YoY Change	-29.3%	135.07%
TOTAL LIABILITIES
Total Short-Term Liabilities	$15.83M	$8.815M
Total Long-Term Liabilities	$3.296M	$4.663M
Total Liabilities	$19.12M	$13.48M
YoY Change	41.87%	10.46%
SHAREHOLDERS EQUITY
Retained Earnings	-$74.35M	-$81.95M
YoY Change	-9.29%	-16.6%
Common Stock	$200.8M	$326.6K
YoY Change	61373.4%	2.65%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$118.2M	$115.6M
YoY Change
Total Liabilities & Shareholders Equity	$137.3M	$129.0M
YoY Change	6.43%	23.31%

Cashflow Statement

Concept	2015 Q2	2014 Q2
OPERATING ACTIVITIES
Net Income	$3.613M	$2.825M
YoY Change	27.89%	-37.76%
Depreciation, Depletion And Amortization	$1.150M	$970.0K
YoY Change	18.56%	40.58%
Cash From Operating Activities	$7.410M	$2.320M
YoY Change	219.4%	-73.64%
INVESTING ACTIVITIES
Capital Expenditures	-$470.0K	-$620.0K
YoY Change	-24.19%	-21.52%
Acquisitions
YoY Change
Other Investing Activities	$690.0K	-$17.19M
YoY Change	-104.01%	-86050.0%
Cash From Investing Activities	$220.0K	-$17.81M
YoY Change	-101.24%	2243.42%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	290.0K	840.0K
YoY Change	-65.48%	-21.5%
NET CHANGE
Cash From Operating Activities	7.410M	2.320M
Cash From Investing Activities	220.0K	-17.81M
Cash From Financing Activities	290.0K	840.0K
Net Change In Cash	7.920M	-14.65M
YoY Change	-154.06%	-260.81%
FREE CASH FLOW
Cash From Operating Activities	$7.410M	$2.320M
Capital Expenditures	-$470.0K	-$620.0K
Free Cash Flow	$7.880M	$2.940M
YoY Change	168.03%	-69.34%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2014Q2	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	1370000
CY2014Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Liabilities BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities	431307
CY2014Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Inventory BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory	1003422
CY2014Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Receivables BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables	1646746
CY2014Q2	us-gaap	Goodwill Goodwill	13352057
CY2014Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired Goodwill And Liabilities Assumed Net BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet	26539660
CY2014Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Property Plant And Equipment BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment	84662
CY2014Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Other BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther	184080
CY2015Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	32910187	shares
CY2014Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1312741	shares
CY2014Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	7.19
CY2014Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	33755718
CY2015Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	1184234	shares
CY2015Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1265486	shares
CY2015Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2015Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	2490973	shares
CY2015Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	6.21
CY2015Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	80000000	shares
CY2015Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	717528	shares
CY2015Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	32902987	shares
CY2015Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2015Q2	us-gaap	Share Price SharePrice	41.27
CY2015Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	466706	shares
CY2015Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued		shares
CY2015Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	9.68
CY2015Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	9.68
CY2015Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	32902987	shares
CY2015Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding		shares
CY2015Q2	us-gaap	Availableforsale Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions1 AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositions1	26	Investment
CY2015Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2015Q2	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	900799
CY2015Q2	us-gaap	Liabilities Current LiabilitiesCurrent	15825671
CY2015Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	3040719
CY2015Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	15040331
CY2015Q2	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	1371000
CY2015Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	11522317
CY2015Q2	us-gaap	Other Liabilities Fair Value Disclosure OtherLiabilitiesFairValueDisclosure	0
CY2015Q2	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	57000
CY2015Q2	us-gaap	Operating Leases Future Minimum Payments Remainder Of Fiscal Year OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear	1178000
CY2015Q2	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	4323556
CY2015Q2	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	1670804
CY2015Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	4114898
CY2015Q2	us-gaap	Common Stock Value CommonStockValue	329030
CY2015Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	200435716
CY2015Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	73550
CY2015Q2	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	1895000
CY2015Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	3296446
CY2015Q2	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	611408
CY2015Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-8197044
CY2015Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2015Q2	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	211288
CY2015Q2	us-gaap	Preferred Stock Value PreferredStockValue
CY2015Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	763743
CY2015Q2	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	1435000
CY2015Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-74345164
CY2015Q2	us-gaap	Stockholders Equity StockholdersEquity	118222538
CY2015Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	137344655
CY2015Q2	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	5672
CY2015Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	4586440
CY2015Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	4303354
CY2015Q2	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	2355000
CY2015Q2	us-gaap	Available For Sale Securities AvailableForSaleSecurities	24378288
CY2015Q2	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	450000
CY2015Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	13594163
CY2015Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Rolling Year Four FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFour	1543000
CY2015Q2	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	3833209
CY2015Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	14463716
CY2015Q2	us-gaap	Available For Sale Securities Debt Securities Noncurrent AvailableForSaleSecuritiesDebtSecuritiesNoncurrent	1223468
CY2015Q2	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	2651661
CY2015Q2	us-gaap	Assets Current AssetsCurrent	93267251
CY2015Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	39977638
CY2015Q2	us-gaap	Goodwill Goodwill	14346057
CY2015Q2	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	3807
CY2015Q2	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	23153147
CY2015Q2	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	8000881
CY2015Q2	us-gaap	Deferred Tax Assets Net Current DeferredTaxAssetsNetCurrent	4928
CY2015Q2	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue	10144000
CY2015Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	37410229
CY2015Q2	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	23154820
CY2015Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Rolling Year Three FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearThree	1707000
CY2015Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Rolling After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseRollingAfterYearFive	1204000
CY2015Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	7318939
CY2015Q2	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	13249754
CY2015Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	40012048
CY2015Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Rolling Year Five FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFive	1528000
CY2015Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	16360523
CY2015Q2	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	2471586
CY2015Q2	us-gaap	Assets Assets	137344655
CY2015Q2	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	17709061
CY2015Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	845000
CY2015Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	846808
CY2015Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	14419602
CY2015Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	29504047
CY2015Q2	us-gaap	Other Receivables Gross Current OtherReceivablesGrossCurrent	523369
CY2015Q2	us-gaap	Construction In Progress Gross ConstructionInProgressGross	76519
CY2015Q2	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLoss	4000
CY2015Q2	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	23154820
CY2015Q2	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	24376423
CY2015Q2	us-gaap	Other Assets Fair Value Disclosure OtherAssetsFairValueDisclosure	0
CY2015Q2	us-gaap	Inventory Net InventoryNet	14305676
CY2015Q2	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	13526113
CY2015Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Rolling Year Two FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearTwo	1707000
CY2015Q2	rgen	Available For Sale Securities Debt Maturities One Through Two Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesOneThroughTwoYearsAmortizedCost	1223276
CY2015Q2	rgen	Impact Of Credit Risk On Fair Value Of Derivatives ImpactOfCreditRiskOnFairValueOfDerivatives	0
CY2015Q2	rgen	Available For Sale Securities Debt Maturities After One Through Two Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsFairValue	1223468
CY2015Q2	rgen	Operating Leases Future Minimum Payments Due In Five Years And Thereafter OperatingLeasesFutureMinimumPaymentsDueInFiveYearsAndThereafter	3728000
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	39829653
CY2014Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1225117	shares
CY2014Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2014Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	80000000	shares
CY2014Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	32774374	shares
CY2014Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2014Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued		shares
CY2014Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	8.31
CY2014Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	32774374	shares
CY2014Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding		shares
CY2014Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2014Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	571080
CY2014Q4	us-gaap	Liabilities Current LiabilitiesCurrent	10682413
CY2014Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	3758511
CY2014Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	13815697
CY2014Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	6819063
CY2014Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	78000
CY2014Q4	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	1135061
CY2014Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	3443570
CY2014Q4	us-gaap	Common Stock Value CommonStockValue	327744
CY2014Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	198064414
CY2014Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	40644
CY2014Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	5879013
CY2014Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	129904
CY2014Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-5773142
CY2014Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2014Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	511588
CY2014Q4	us-gaap	Preferred Stock Value PreferredStockValue
CY2014Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	712919
CY2014Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-80887208
CY2014Q4	us-gaap	Stockholders Equity StockholdersEquity	111731808
CY2014Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	128293234
CY2014Q4	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	26643408
CY2014Q4	us-gaap	Inventory Net InventoryNet	12383633
CY2014Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	7760382
CY2014Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	28341937
CY2014Q4	us-gaap	Other Receivables Gross Current OtherReceivablesGrossCurrent	239890
CY2014Q4	us-gaap	Construction In Progress Gross ConstructionInProgressGross	3847746
CY2014Q4	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	23090209
CY2014Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	6403
CY2014Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	3844574
CY2014Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	3863350
CY2014Q4	us-gaap	Available For Sale Securities AvailableForSaleSecurities	26640419
CY2014Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	450000
CY2014Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	14636307
CY2014Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	4753508
CY2014Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	14526240
CY2014Q4	us-gaap	Available For Sale Securities Debt Securities Noncurrent AvailableForSaleSecuritiesDebtSecuritiesNoncurrent	3550210
CY2014Q4	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	2270347
CY2014Q4	us-gaap	Assets Current AssetsCurrent	80945642
CY2014Q4	us-gaap	Goodwill Goodwill	14184835
CY2014Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	9392
CY2014Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	5373860
CY2014Q4	us-gaap	Deferred Tax Assets Net Current DeferredTaxAssetsNetCurrent	4928
CY2014Q4	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	9108214
CY2014Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	35363024
CY2014Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	2256265
CY2014Q4	us-gaap	Assets Assets	128293234
CY2014Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	18079877
CY2014Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2103576
CY2014Q4	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	13115630
CY2014Q4	rgen	Expected Effective Income Tax Rate For Current Fiscal Year ExpectedEffectiveIncomeTaxRateForCurrentFiscalYear	0.2423	pure
CY2014Q2	us-gaap	Business Combination Consideration Transferred Equity Interests Issued And Issuable BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable	4000000
CY2014Q2	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	21169660
CY2014Q2	us-gaap	Business Combination Consideration Transferred1 BusinessCombinationConsiderationTransferred1	26539660
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	300908	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	32098269	shares
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.178	pure
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	10320326
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	10.85
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.22
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	32963554	shares
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.22
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	865285	shares
	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	-6354278
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	5508834
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1224091
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	8641354
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	67785
	us-gaap	Operating Income Loss OperatingIncomeLoss	8413698
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	286261
	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-2640
	us-gaap	Revenues Revenues	31876930
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	2547815
	us-gaap	Investment Income Net InvestmentIncomeNet	186736
	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	29885764
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	300432
	us-gaap	Gain Loss On Investments GainLossOnInvestments	0
	us-gaap	Net Income Loss NetIncomeLoss	7102525
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	12066
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	18635241
	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	21235937
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	646322
	us-gaap	Royalty Revenue RoyaltyRevenue	1991166
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-1605757
	us-gaap	Increase In Restricted Cash IncreaseInRestrictedCash	250000
	us-gaap	Income Taxes Paid IncomeTaxesPaid	668000
	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	35659000
	us-gaap	Interest Expense InterestExpense	26865
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-878891
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1855392
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	1337906
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1538829
	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	24491993
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	116020
	us-gaap	Costs And Expenses CostsAndExpenses	23463232
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	153704
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-6073935
	us-gaap	Direct Operating Cost Royalty Expense DirectOperatingCostRoyaltyExpense	0
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	2069947
	us-gaap	Share Based Compensation ShareBasedCompensation	852637
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	7709444
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-4844919
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-16853276
	us-gaap	Cost Of Goods Sold CostOfGoodsSold	13006645
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	1337906
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2631123
	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-207390
	dei	Document Type DocumentType	10-Q
	dei	Trading Symbol TradingSymbol	RGEN
	dei	Entity Central Index Key EntityCentralIndexKey	0000730272
	dei	Document Period End Date DocumentPeriodEndDate	2015-06-30
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	224182	shares
	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	150041	shares
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	8.96
	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y11M19D
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	14.31
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	32827536	shares
	us-gaap	Finite Lived Intangible Asset Useful Life FiniteLivedIntangibleAssetUsefulLife	P10Y
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.235	pure
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	5113034
	dei	Amendment Flag AmendmentFlag	false
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	55200	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	5.03
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	128613	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	21.83
	dei	Entity Registrant Name EntityRegistrantName	REPLIGEN CORP
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.20
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	Segment
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y2M23D
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2015
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	33581682	shares
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.19
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P7Y2M9D
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	754146	shares
	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	42273543
	us-gaap	Payments Of Merger Related Costs Financing Activities PaymentsOfMergerRelatedCostsFinancingActivities	99000
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-2401571
	us-gaap	Income Taxes Paid IncomeTaxesPaid	1629000
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	1879607
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-981580
	us-gaap	Gain Loss On Investments GainLossOnInvestments	0
	us-gaap	Net Income Loss NetIncomeLoss	6542044
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-22331
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	8118938
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	1521511
	us-gaap	Basis Of Accounting BasisOfAccounting	<div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; WORD-SPACING: 0px; WIDOWS: 1; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td valign="top" width="4%" align="left"><b>1.</b></td> <td valign="top" align="left"><b>Basis of Presentation</b></td> </tr> </table> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 6pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> The consolidated financial statements included herein have been prepared by Repligen Corporation (the “Company,” “Repligen” or “we”) in accordance with generally accepted accounting principles in the United States (“U.S. GAAP”) and pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”), for Quarterly Reports on Form 10-Q and Article 10 of Regulation S-X and do not include all of the information and footnote disclosures required by U.S. GAAP. These consolidated financial statements should be read in conjunction with the audited consolidated financial statements and accompanying notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2014.</p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> In the opinion of management, the accompanying unaudited consolidated financial statements include all adjustments, consisting of only normal, recurring adjustments necessary for a fair presentation of the financial position, results of operations and cash flows. The results of operations for the interim periods presented are not necessarily indicative of results to be expected for the entire year.</p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 18pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> <b><i>Recently Issued Accounting Pronouncements</i></b></p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 6pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> In May 2014, the FASB issued ASU No. 2014-09, which amends the guidance for accounting for revenue from contracts with customers. This ASU supersedes the revenue recognition requirements in Accounting Standards Codification Topic 605, <i>Revenue Recognition</i>, and creates a new Topic 606, <i>Revenue from Contracts with Customers</i>. This guidance is expected to be effective for fiscal years beginning after December 15, 2017, with early adoption permitted in fiscal years beginning after December 15, 2016. Two adoption methods are permitted: retrospectively to all prior reporting periods presented, with certain practical expedients permitted; or retrospectively with the cumulative effect of initially adopting the ASU recognized at the date of initial application. The Company has not yet determined which adoption method it will utilize or the effect that the adoption of this guidance will have on its consolidated financial statements.</p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; TEXT-TRANSFORM: none; WORD-SPACING: 0px; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> In July 2015, the FASB issued ASU 2015-11, “Simplifying the Measurement of Inventory,” (“ASU 2015-11”). ASU 2015-11 requires inventory be measured at the lower of cost and net realizable value and options that currently exist for market value be eliminated. ASU 2015-11 defines net realizable value as estimated selling prices in the ordinary course of business, less reasonably predictable costs of completion, disposal, and transportation. The guidance is effective prospectively for reporting periods beginning after December 15, 2016 and interim periods within those fiscal years with early adoption permitted. The Company does not expect the adoption of ASU 2015-11 to have a material impact on its consolidated financial statements.</p> </div>
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P5Y4D
	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	283478
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	4118142
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1736695
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	8549861
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-136518
	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax	-2423902
	us-gaap	Operating Income Loss OperatingIncomeLoss	8647611
	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-2423902
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	2380129
	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-1156
	us-gaap	Revenues Revenues	42273543
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	6853392
	us-gaap	Investment Income Net InvestmentIncomeNet	55597
	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	42274000
	us-gaap	Interest Expense InterestExpense	16829
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-1553773
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2295569
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	586661
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	801000
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2007817
	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	10358735
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	1880930
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	32902
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements	1137741
	us-gaap	Costs And Expenses CostsAndExpenses	33625932
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	173105
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	4649024
	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci On Derivatives Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax	0
	us-gaap	Direct Operating Cost Royalty Expense DirectOperatingCostRoyaltyExpense	0
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	586581
	us-gaap	Share Based Compensation ShareBasedCompensation	1686926
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	12266801
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	874652
	us-gaap	Deferred Revenue Revenue Recognized DeferredRevenueRevenueRecognized	2115000
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	503102
	us-gaap	Cost Of Goods Sold CostOfGoodsSold	16659051
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	685661
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2819150
	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-425413
	rgen	Nonrefundable Upfront Cash Payment Under Collaborations Agreement NonrefundableUpfrontCashPaymentUnderCollaborationsAgreement	2000000
	rgen	Long Term Marketable Securities Maturities Term Minimum LongTermMarketableSecuritiesMaturitiesTermMinimum	P1Y
	rgen	Payment To Be Received Upon Signing Of Agreement PaymentToBeReceivedUponSigningOfAgreement	125675
	rgen	Marketable Securities Remaining Maturity MarketableSecuritiesRemainingMaturity	P5M23D
CY2014Q1	rgen	Lease Commencement Date LeaseCommencementDate	2014-08-01
CY2014Q1	rgen	Lease Agreement Term LeaseAgreementTerm	P8Y1M
CY2014	us-gaap	Finite Lived Intangible Asset Useful Life FiniteLivedIntangibleAssetUsefulLife	P10Y
CY2014Q1	rgen	Non Contingent Consideration Being Recognized As Revenue Over Estimated Period Of Performance NonContingentConsiderationBeingRecognizedAsRevenueOverEstimatedPeriodOfPerformance	2000000
CY2014Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	264317	shares
CY2014Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	32233694	shares
CY2014Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.09
CY2014Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	33076384	shares
CY2014Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.09
CY2014Q2	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	842690	shares
CY2014Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	1372701
CY2014Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	3243249
CY2014Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	65280
CY2014Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	3105829
CY2014Q2	us-gaap	Revenues Revenues	15551077
CY2014Q2	us-gaap	Investment Income Net InvestmentIncomeNet	84920
CY2014Q2	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	15551077
CY2014Q2	us-gaap	Net Income Loss NetIncomeLoss	2825422
CY2014Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	9882
CY2014Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-1462603
CY2014Q2	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	17707000
CY2014Q2	us-gaap	Interest Expense InterestExpense	12780
CY2014Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	417827
CY2014Q2	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	17700
CY2014Q2	us-gaap	Costs And Expenses CostsAndExpenses	12445248
CY2014Q2	us-gaap	Direct Operating Cost Royalty Expense DirectOperatingCostRoyaltyExpense	0
CY2014Q2	us-gaap	Share Based Compensation ShareBasedCompensation	545212
CY2014Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	4325834
CY2014Q2	us-gaap	Cost Of Goods Sold CostOfGoodsSold	6671581
CY2014Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1430133
CY2015Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	126541	shares
CY2015Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	32870473	shares
CY2015Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.11
CY2015Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	33670696	shares
CY2015Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.11
CY2015Q2	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	800223	shares
CY2015Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	5054633
CY2015Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	4351388
CY2015Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-268549
CY2015Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	4608713
CY2015Q2	us-gaap	Revenues Revenues	21457267
CY2015Q2	us-gaap	Investment Income Net InvestmentIncomeNet	19012
CY2015Q2	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	21457267
CY2015Q2	us-gaap	Net Income Loss NetIncomeLoss	3612557
CY2015Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-4962
CY2015Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	1447038
CY2015Q2	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	21457000
CY2015Q2	us-gaap	Interest Expense InterestExpense	7788
CY2015Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	738831
CY2015Q2	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	768556
CY2015Q2	us-gaap	Costs And Expenses CostsAndExpenses	16848554
CY2015Q2	us-gaap	Direct Operating Cost Royalty Expense DirectOperatingCostRoyaltyExpense	0
CY2015Q2	us-gaap	Share Based Compensation ShareBasedCompensation	984944
CY2015Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	6242275
CY2015Q2	us-gaap	Cost Of Goods Sold CostOfGoodsSold	8586147
CY2015Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1251576

Files In Submission

Name	View Source	Status
0001193125-15-280610-index-headers.html	Edgar Link	pending
0001193125-15-280610-index.html	Edgar Link	pending
0001193125-15-280610.txt	Edgar Link	pending
0001193125-15-280610-xbrl.zip	Edgar Link	pending
d946073d10q.htm	Edgar Link	pending
d946073dex101.htm	Edgar Link	pending
d946073dex311.htm	Edgar Link	pending
d946073dex312.htm	Edgar Link	pending
d946073dex321.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
rgen-20150630.xml	Edgar Link	completed
rgen-20150630.xsd	Edgar Link	pending
rgen-20150630_cal.xml	Edgar Link	unprocessable
rgen-20150630_def.xml	Edgar Link	unprocessable
rgen-20150630_lab.xml	Edgar Link	unprocessable
rgen-20150630_pre.xml	Edgar Link	unprocessable
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$RGEN
REPLIGEN CORP Stock $rgen

2015 Q2 Form 10-Q Financial Statement

#000119312515280610 Filed on August 06, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$RGEN REPLIGEN CORP Stock $rgen

2015 Q2 Form 10-Q Financial Statement

#000119312515280610 Filed on August 06, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$RGEN
REPLIGEN CORP Stock $rgen